Seaport Therapeutics, Inc.
SPTX
$24.22
$0.512.15%
NASDAQ
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 573.90% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 143.08% | ||||
| Operating Income | -143.08% | ||||
| Income Before Tax | -150.51% | ||||
| Income Tax Expenses | -51.64% | ||||
| Earnings from Continuing Operations | -146.38% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -146.38% | ||||
| EBIT | -143.08% | ||||
| EBITDA | -143.21% | ||||
| EPS Basic | 82.82% | ||||
| Normalized Basic EPS | 82.53% | ||||
| EPS Diluted | 82.82% | ||||
| Normalized Diluted EPS | 82.53% | ||||
| Average Basic Shares Outstanding | 1,334.23% | ||||
| Average Diluted Shares Outstanding | 1,334.23% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||